Teva Pharmaceutical Industries (TEVA) Change in Acquisitions & Divestments (2016 - 2025)
Historic Change in Acquisitions & Divestments for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Q4 2025 value amounting to $42.0 million.
- Teva Pharmaceutical Industries' Change in Acquisitions & Divestments changed N/A to $42.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $82.0 million, marking a year-over-year increase of 10500.0%. This contributed to the annual value of $42.0 million for FY2025, which is 500.0% up from last year.
- As of Q4 2025, Teva Pharmaceutical Industries' Change in Acquisitions & Divestments stood at $42.0 million.
- Over the past 5 years, Teva Pharmaceutical Industries' Change in Acquisitions & Divestments peaked at $107.0 million during Q2 2021, and registered a low of $1.0 million during Q3 2022.
- In the last 4 years, Teva Pharmaceutical Industries' Change in Acquisitions & Divestments had a median value of $40.0 million in 2024 and averaged $36.9 million.
- As far as peak fluctuations go, Teva Pharmaceutical Industries' Change in Acquisitions & Divestments surged by 346666.67% in 2021, and later crashed by 9719.63% in 2022.
- Quarter analysis of 4 years shows Teva Pharmaceutical Industries' Change in Acquisitions & Divestments stood at $19.0 million in 2021, then tumbled by 94.74% to $1.0 million in 2022, then soared by 3900.0% to $40.0 million in 2024, then increased by 5.0% to $42.0 million in 2025.
- Its Change in Acquisitions & Divestments stands at $42.0 million for Q4 2025, versus $40.0 million for Q3 2024 and $1.0 million for Q3 2022.